COMPLIANCE CAN BE EASY TO ACHIEVE
FDA UDI, EU MDR, FDA PART 11, EU Clinical trials
regulations can be easily implemented with the right
Let us help you
IS YOUR ROLE REGULATORY OR COMPLIANCE?
Ensuring that your company is fully compliant with all required laws and regulations, is not only fundamental but also incredibly time-consuming. However, as important, is ensuring you remain fully up-to-speed on all aspects of legal change.
Our internal regulatory experts quote: “If you cannot prove it, it did not happen.”
We understand that you need to be supported by highly efficient Label Management Software and documentation for all aspects of compliance - from FDA 21 CFR Part 11, Audit logs, Approval Workflows, Language and Phrase Controls, Print Inspection, and Versions Control to Regulatory Rules and Security.
We support every element of validation - from initial installation to final performance testing, if support is required. Our software is supplied as a validatable package, including auditable security protocols and lifecycle documentation, based on the GAMP 5 model.
“Security and regulatory compliance is of paramount importance in medical device manufacturing. PRISYM ID’s labeling system is able to provide us with the correct level of service and security we require, whilst being user friendly.
The install of the system into our clean room went smoothly and we have been pleased with the results.”
CHOSEN BY THESE CUSTOMERS...
OFFERING THESE PRODUCTS AND SERVICES...
This solution provides organizations with complete label integrity to meet the strictest compliance requirements for FDA & EU regulations, specifically FDA 21 CFR Parts 11, 810, and 820.
REGULATORY AND COMPLIANCE LABELING RESOURCES
Join PRISYM ID for this free webinar to learn how an effective “touch your label once” strategy for EU MDR labeling can streamline processes and reduce the cost of a global label change.
Whether you’re producing medical devices within Europe or supplying to Europe, as a manufacturer or supplier, you will need to adhere to the new EU MDR.